Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BCB
|
|||
| Former ID |
DIB011145
|
|||
| Drug Name |
Lobeglitazone
|
|||
| Synonyms |
Lobeglitazone sulfate; CKD-501; Dual PPARalpha/delta (type 2 diabetes), Chong Kun Dang
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11] | Approved | [1] | |
| Company |
Chong Kun Dang Pharmaceutical Corp
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H24N4O5S
|
|||
| Canonical SMILES |
CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC
|
|||
| InChI |
1S/C24H24N4O5S/c1-28(21-14-22(26-15-25-21)33-19-9-7-17(31-2)8-10-19)11-12-32-18-5-3-16(4-6-18)13-20-23(29)27-24(30)34-20/h3-10,14-15,20H,11-13H2,1-2H3,(H,27,29,30)
|
|||
| InChIKey |
CHHXEZSCHQVSRE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 607723-33-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:136052
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, after a single oral administration in healthy female subjects. Clin Drug Investig. 2014 Jul;34(7):467-74. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.